Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease

Prognostic Impact of Concomitant p53 and PTEN on Outcome in Early Stage (FIGO I-II) Epithelial Ovarian Cancer

(2011) Ingirídur Skírnisdóttir et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Prognostic Impact of p53, p27, and C-MYC on Clinicopathological Features and Outcome in Early-Stage (FIGO I-II) Epithelial Ovarian Cancer

(2011) Ingirídur Anna Skírnisdóttir et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Recognition of potential predictive markers for diagnosis in Korean serous ovarian cancer patients at stage IIIc using array comparative genomic hybridization with high resolution

(2011) Jee Young Kwon et al.   Molecular & Cellular Toxicology

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Identification of Tumor Suppressors and Oncogenes from Genomic and Epigenetic Features in Ovarian Cancer

(2011) Kazimierz O. Wrzeszczynski et al.   PLoS One

Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity

(2011) Markus Rasmussen et al.   GENOME BIOLOGY

Translational research in the Gynecologic Oncology Group: Evaluation of ovarian cancer markers, profiles, and novel therapies

(2010) Kathleen M. Darcy et al.   GYNECOLOGIC ONCOLOGY

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

(2010) Ahmed Ashour Ahmed et al.   JOURNAL OF PATHOLOGY

Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer

(2010) Kylie L. Gorringe et al.   PLoS One

Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome

(2009) A. Berchuck et al.   CLINICAL CANCER RESEARCH

Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas

(2009) D. Etemadmoghadam et al.   CLINICAL CANCER RESEARCH

Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis

(2009) Kylie L. Gorringe et al.   GENES CHROMOSOMES & CANCER

Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer

(2009) Jeremy Chien et al.   GYNECOLOGIC ONCOLOGY

Survival after recurrence in early-stage high-risk epithelial ovarian cancer: A Gynecologic Oncology Group study

(2009) John K. Chan et al.   GYNECOLOGIC ONCOLOGY

Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications

(2009) Martin Köbel et al.   GYNECOLOGIC ONCOLOGY

Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients

(2009) R Gunnarsson et al.   LEUKEMIA

Ovarian Cancer: A Clinical Challenge That Needs Some Basic Answers

(2009) Kate Lawrenson et al.   PLOS MEDICINE

Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers

(2008) Kathleen M. Darcy et al.   GYNECOLOGIC ONCOLOGY

A novel approach for reliable microarray analysis of microdissected tumor cells from formalin-fixed and paraffin-embedded colorectal cancer resection specimens

(2008) Silke Lassmann et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Gene-expression profiling in epithelial ovarian cancer

(2008) Panagiotis A Konstantinopoulos et al.   Nature clinical practice. Oncology

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

(2008) Martin Köbel et al.   PLOS MEDICINE